| Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform I Fornacon-Wood, H Mistry, CJ Ackermann, F Blackhall, A McPartlin, ... European radiology 30, 6241-6250, 2020 | 183 | 2020 |
| An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment MR Davies, HB Mistry, L Hussein, CE Pollard, JP Valentin, J Swinton, ... American Journal of Physiology-Heart and Circulatory Physiology 302 (7 …, 2012 | 92 | 2012 |
| Oxygen-enhanced MRI is feasible, repeatable, and detects radiotherapy-induced change in hypoxia in xenograft models and in patients with non–small cell lung cancer A Salem, RA Little, A Latif, AK Featherstone, M Babur, I Peset, S Cheung, ... Clinical Cancer Research 25 (13), 3818-3829, 2019 | 85 | 2019 |
| Understanding the differences between Bayesian and frequentist statistics I Fornacon-Wood, H Mistry, C Johnson-Hart, C Faivre-Finn, JPB O'Connor, ... International journal of radiation oncology, biology, physics 112 (5), 1076-1082, 2022 | 77 | 2022 |
| The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance A Selen, PA Dickinson, A Müllertz, JR Crison, HB Mistry, MT Cruañes, ... Journal of Pharmaceutical Sciences 103 (11), 3377-3397, 2014 | 74 | 2014 |
| Long-term outcomes of radical radiation therapy with hypoxia modification with biomarker discovery for stratification: 10-year update of the BCON (bladder carbogen nicotinamide … YP Song, H Mistry, J Irlam, H Valentine, L Yang, B Lane, C West, ... International Journal of Radiation Oncology* Biology* Physics 110 (5), 1407-1415, 2021 | 64 | 2021 |
| Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy N Joseph, A McWilliam, J Kennedy, K Haslett, J Mahil, A Gavarraju, ... Radiotherapy and Oncology 135, 115-119, 2019 | 54 | 2019 |
| Association of chemoradiotherapy with outcomes among patients with stage I to II vs stage III small cell lung cancer: secondary analysis of a randomized clinical trial A Salem, H Mistry, M Hatton, I Locke, I Monnet, F Blackhall, C Faivre-Finn JAMA oncology 5 (3), e185335-e185335, 2019 | 53 | 2019 |
| Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase HB Mistry, DE MacCallum, RC Jackson, MAJ Chaplain, FA Davidson Proceedings of the National Academy of Sciences 105 (51), 20215-20220, 2008 | 52 | 2008 |
| Severity and threshold of peanut reactivity during hospital‐based open oral food challenges: An international multicenter survey PD Arkwright, J MacMahon, J Koplin, S Rajput, S Cross, R Fitzsimons, ... Pediatric Allergy and Immunology 29 (7), 754-761, 2018 | 46 | 2018 |
| Loss of function in Escherichia coli exposed to environmentally relevant concentrations of benzalkonium chloride S Forbes, N Morgan, GJ Humphreys, A Amézquita, H Mistry, AJ McBain Applied and environmental microbiology 85 (4), e02417-18, 2019 | 45 | 2019 |
| Bladder-sparing treatment with radical dose radiotherapy is an effective alternative to radical cystectomy in patients with clinically node-positive nonmetastatic bladder cancer M Swinton, NBG Mariam, JL Tan, K Murphy, T Elumalai, M Soni, A Ferrera, ... Journal of Clinical Oncology 41 (27), 4406-4415, 2023 | 37 | 2023 |
| Compliance and outcome of elderly patients treated in the concurrent once-daily versus twice-daily radiotherapy (CONVERT) trial M Christodoulou, F Blackhall, H Mistry, A Leylek, J Knegjens, ... Journal of thoracic oncology 14 (1), 63-71, 2019 | 36 | 2019 |
| Ten-year outcomes of moderately hypofractionated salvage postprostatectomy radiation therapy and external validation of a contemporary multivariable nomogram for biochemical … S Chin, A Fatimilehin, R Walshaw, A Argarwal, H Mistry, T Elliott, J Logue, ... International Journal of Radiation Oncology* Biology* Physics 107 (2), 288-296, 2020 | 35 | 2020 |
| Formulation of biocides increases antimicrobial potency and mitigates the enrichment of nonsusceptible bacteria in multispecies biofilms S Forbes, N Cowley, G Humphreys, H Mistry, A Amézquita, AJ McBain Applied and environmental microbiology 83 (7), e03054-16, 2017 | 33 | 2017 |
| Palliative radiation therapy in bladder cancer—importance of patient selection: a retrospective multicenter study A Ali, YP Song, S Mehta, H Mistry, R Conroy, C Coyle, J Logue, A Tran, ... International Journal of Radiation Oncology* Biology* Physics 105 (2), 389-393, 2019 | 32 | 2019 |
| Optimizing clinical drug product performance: applying biopharmaceutics risk assessment roadmap (BioRAM) and the BioRAM scoring grid PA Dickinson, F Kesisoglou, T Flanagan, MN Martinez, HB Mistry, ... Journal of Pharmaceutical Sciences 105 (11), 3243-3255, 2016 | 30 | 2016 |
| 18F-Fludeoxyglucose PET/CT in SCLC: analysis of the CONVERT randomized controlled trial P Manoharan, A Salem, H Mistry, M Gornall, S Harden, P Julyan, I Locke, ... Journal of Thoracic Oncology 14 (7), 1296-1305, 2019 | 29 | 2019 |
| A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment HB Mistry, MR Davies, GY Di Veroli Frontiers in Pharmacology 6, 59, 2015 | 29 | 2015 |
| Is tumour sphericity an important prognostic factor in patients with lung cancer? A Davey, M Van Herk, C Faivre-Finn, H Mistry, A McWilliam Radiotherapy and Oncology 143, 73-80, 2020 | 28 | 2020 |
